Skip to main content
Journal cover image

Multisite Study of the Management of Musculoskeletal Infection After Trauma: The MMUSKIT Study.

Publication ,  Journal Article
Seidelman, J; Ritter, AS; Poehlein, E; Green, CL; Briggs, DV; Chari, T; Therien, AD; Aitchison, AH; Lunn, K; Zirbes, CF; Manohar, T; Rijo, DV ...
Published in: Open Forum Infect Dis
June 2024

BACKGROUND: The optimal duration and choice of antibiotic for fracture-related infection (FRI) is not well defined. This study aimed to determine whether antibiotic duration (≤6 vs >6 weeks) is associated with infection- and surgery-free survival. The secondary aim was to ascertain risk factors associated with surgery- and infection-free survival. METHODS: We performed a multicenter retrospective study of patients diagnosed with FRI between 2013 and 2022. The association between antibiotic duration and surgery- and infection-free survival was assessed by Cox proportional hazard models. Models were weighted by the inverse of the propensity score, calculated with a priori variables of hardware removal; infection due to Staphylococcus aureus, Staphylococcus lugdunensis, Pseudomonas or Candida species; and flap coverage. Multivariable Cox proportional hazard models were run with additional covariates including initial pathogen, need for flap, and hardware removal. RESULTS: Of 96 patients, 54 (56.3%) received ≤6 weeks of antibiotics and 42 (43.7%) received >6 weeks. There was no association between longer antibiotic duration and surgery-free survival (hazard ratio [HR], 0.95; 95% CI, .65-1.38; P = .78) or infection-free survival (HR, 0.77; 95% CI, .30-1.96; P = .58). Negative culture was associated with increased hazard of reoperation or death (HR, 3.52; 95% CI, 1.99-6.20; P < .001) and reinfection or death (HR, 3.71; 95% CI, 1.24-11.09; P < .001). Need for flap coverage had an increased hazard of reoperation or death (HR, 3.24; 95% CI, 1.61-6.54; P = .001). CONCLUSIONS: The ideal duration of antibiotics to treat FRI is unclear. In this multicenter study, there was no association between antibiotic treatment duration and surgery- or infection-free survival.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Open Forum Infect Dis

DOI

ISSN

2328-8957

Publication Date

June 2024

Volume

11

Issue

6

Start / End Page

ofae262

Location

United States

Related Subject Headings

  • 3207 Medical microbiology
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Seidelman, J., Ritter, A. S., Poehlein, E., Green, C. L., Briggs, D. V., Chari, T., … Nelson, S. B. (2024). Multisite Study of the Management of Musculoskeletal Infection After Trauma: The MMUSKIT Study. Open Forum Infect Dis, 11(6), ofae262. https://doi.org/10.1093/ofid/ofae262
Seidelman, Jessica, Alaina S. Ritter, Emily Poehlein, Cynthia L. Green, Damon V. Briggs, Tristan Chari, Aaron D. Therien, et al. “Multisite Study of the Management of Musculoskeletal Infection After Trauma: The MMUSKIT Study.Open Forum Infect Dis 11, no. 6 (June 2024): ofae262. https://doi.org/10.1093/ofid/ofae262.
Seidelman J, Ritter AS, Poehlein E, Green CL, Briggs DV, Chari T, et al. Multisite Study of the Management of Musculoskeletal Infection After Trauma: The MMUSKIT Study. Open Forum Infect Dis. 2024 Jun;11(6):ofae262.
Seidelman, Jessica, et al. “Multisite Study of the Management of Musculoskeletal Infection After Trauma: The MMUSKIT Study.Open Forum Infect Dis, vol. 11, no. 6, June 2024, p. ofae262. Pubmed, doi:10.1093/ofid/ofae262.
Seidelman J, Ritter AS, Poehlein E, Green CL, Briggs DV, Chari T, Therien AD, Aitchison AH, Lunn K, Zirbes CF, Manohar T, Rijo DV, Hagen JE, Talerico MT, DeBaun MR, Pean CA, Certain L, Nelson SB. Multisite Study of the Management of Musculoskeletal Infection After Trauma: The MMUSKIT Study. Open Forum Infect Dis. 2024 Jun;11(6):ofae262.
Journal cover image

Published In

Open Forum Infect Dis

DOI

ISSN

2328-8957

Publication Date

June 2024

Volume

11

Issue

6

Start / End Page

ofae262

Location

United States

Related Subject Headings

  • 3207 Medical microbiology
  • 3202 Clinical sciences